| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 101.01B | 97.16B | 86.66B | 59.98B | 38.71B | 22.74B |
| Gross Profit | 58.76B | 74.65B | 67.26B | 57.42B | 36.82B | 21.84B |
| EBITDA | 5.30B | 5.15B | 2.39B | 721.77M | -2.71B | -1.06B |
| Net Income | 4.89B | 4.25B | 1.82B | 355.47M | -2.96B | -1.23B |
Balance Sheet | ||||||
| Total Assets | 233.33B | 217.60B | 176.82B | 143.95B | 109.89B | 66.49B |
| Cash, Cash Equivalents and Short-Term Investments | 1.41B | 2.39B | 3.56B | 15.70B | 28.99B | 13.57B |
| Total Debt | 3.50B | 3.50B | 3.50B | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 186.31B | 171.47B | 142.39B | 110.48B | 80.70B | 47.74B |
| Stockholders Equity | 47.03B | 46.12B | 34.43B | 33.47B | 29.19B | 18.75B |
Cash Flow | ||||||
| Free Cash Flow | 8.73B | 15.86B | 17.04B | 22.29B | 24.29B | 15.36B |
| Operating Cash Flow | 8.82B | 16.04B | 17.20B | 22.50B | 24.71B | 15.63B |
| Investing Cash Flow | -9.68B | -28.37B | -19.86B | -25.14B | -34.87B | -16.37B |
| Financing Cash Flow | -126.30M | 10.92B | 3.42B | 3.97B | 10.03B | 1.59B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ₹882.20B | 30.69 | ― | 0.69% | 12.68% | 9.94% | |
72 Outperform | ₹291.54B | 56.68 | ― | ― | 7.86% | 38.61% | |
70 Outperform | ₹701.67B | 9.68 | ― | 2.69% | 11.99% | 28.15% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
60 Neutral | ₹140.33B | 175.19 | ― | ― | -28.49% | -34.90% | |
55 Neutral | ₹309.14B | 5.31 | ― | 1.87% | 4.31% | 6.48% | |
49 Neutral | ₹371.07B | 64.91 | ― | ― | 43.91% | 97.85% |